Webinars

Application of sandwich-cultured hepatocytes and the B-Clear assay for the IVIVE of hepatic clearance, drug-drug interactions and unbound intracellular drug concentrations
Sulfate Conjugates as Solute Carrier Transporter Substrates; Probes, Biomarkers, and Utility?
Combining transporter data with quantitative systems toxicology modeling (DILIsym) to impact decisions in drug development
The potential of engineered human liver co-cultures in phenotypic drug discovery for liver diseases
The utility of microscale human liver co-cultures for investigating drug toxicity outcomes
Using micropatterned co-cultures to model human-specific drug metabolism, disposition and drug-drug interactions
Engineering Micropatterned Co-cultures for Drug Development
The Promises of Quantitative Transporter Proteomics: IVIVE to Precision Medicine
Understanding Hepatobiliary Disposition:The Importance of an Integrative Platform in Evaluating Transporter Interactions
Predictive cross-species proximal tubule cell models for drug development and safety assessment studies
Transporter-Ā­driven Vectorial Transport of Cationic, Anionic, and Zwitterionic Drugs in the Intestine
Role of inhibition of the bile salt export pump (BSEP) in drug induced liver injury
Imaging of ABC transporters at the blood-brain barrier with positron emission tomography
Principles of Transporter Drug Interactions with Special Focus on Hepatic and BBB Transporters
Managing Digoxin DDI by the P-gp IC50 working group & Practical methods to assess role of hepatic uptake transporters